Repository logo
 

Associations between bacterial infections and blood pressure in pregnancy

Accepted version
Peer-reviewed

Change log

Authors

Petry, CJ 
Hughes, I 

Abstract

OBJECTIVES: To test the hypothesis that bacterial infections in pregnancy are related to maternal blood pressure. STUDY DESIGN: Bacterial infection was assessed using antibiotic usage as a surrogate and its association with blood pressure in pregnancy tested in the Cambridge Baby Growth Study. MAIN OUTCOME MEASURES: Antibiotic usage in pregnancy was self-reported in questionnaires. Blood pressure measurements at four time points in pregnancy were collected from the hospital notes of 622 women. RESULTS: Using all the available blood pressure readings (adjusted for weeks gestation) antibiotic usage was associated with a higher mean arterial blood pressure across pregnancy: antibiotics used 85 (84, 87) mmHg vs. no antibiotics used 83 (83, 84) mmHg (β = 2.3 (0.6, 4.0) mmHg, p = 9.6 × 10−3, from 621 individuals). Further analysis revealed that antibiotic usage was associated with diastolic (β = 2.3 (0.6, 4.0) mmHg; p = 7.0 × 10−3) more than systolic blood pressure (β = 1.4 (−0.9, 3.7) mmHg; p = 0.2). The effect size associated with antibiotic usage appeared to rise slightly after the first trimester. CONCLUSIONS: Bacterial infection in pregnancy, as assessed by self-reported antibiotic usage, is associated with small rises in blood pressure.

Description

Keywords

pregnancy, antibiotics, pre-eclampsia, gestational hypertension

Journal Title

Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health

Conference Name

Journal ISSN

2210-7789
2210-7797

Volume Title

Publisher

Elsevier
Sponsorship
Wellbeing of Women (RG1644)
MRC Epidemiology Unit (7500001180)
Cambridge University Hospitals NHS Foundation Trust (CUH)
Medical Research Council (MC_UU_12015/2)
Medical Research Council (G0600717)
Medical Research Council (G0500733)
Diabetes UK (11/0004241)
Medical Research Council (G0500733/1)
Medical Research Council (G0600717/1)
Funding for this study has come from the Evelyn Trust (EW9035322), Diabetes UK (11/0004241) and the Wellbeing of Women (the Royal College of Obstetricians and Gynaecologists, UK) (RG1644). Other core funding has come from the Medical Research Council (7500001180), European Union Framework 5 (QLK4-1999-01422), the Mothercare Charitable Foundation (RG54608), Newlife Foundation for Disabled Children (07/20), and the World Cancer Research Fund International (2004/03). In addition, there has been support from National Institute for Health Research Cambridge Biomedical Research Centre. The sponsors did not have any role in the study design, in the collection, analysis or the interpretation of the data, in the writing of the manuscript or in the decision to submit it for publication.